Drugs / 11(R)-rolipram
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05522673 | Feb 2023 | major depressive disorder | National Institute of Mental Health (NIMH) | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11(R)-rolipram | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05522673 ↗ |
| Route | Intravenous | “received 20 mCi of \[11C\](R)-rolipram intravenously for two PET scans” NCT05522673 ↗ |